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IN this communication data are given ofthe occurrence ofspontaneous tumours
of the forestomach in the inbred strains of mice, CBA and NBT, and in the F1
and succeeding generations oftheir reciprocal hybrids, and ofthe effect ofthe sub-
cutaneous administration of methylcholanthrene upon the incidence of the same
types of neoplasm in these same inbred and hybrid strains.
MATERIAL.
As previously described in detail (Miller and Pybus, 1954a), the inbred NBT
and CBA strains were crossed reciprocally to give the NBT/CBA (or NC) and
CBA/NBT (or CN) hybrid strains. Half of the F1 mice each received one sub-
cutaneous injection of 1.0 mg. methylcholanthrene in 0-1 c.c. sesame oil at the
age of 2 months. These injected mice and their descendants, similarly injected,
were bred from, brother to sister, for a total of 10 generations, and a further 2
generations ofuninjected mice were bred, to give a total of 12 generations ofMNC
and MCN hybrids. The other half of the F1 mice were not injected but were
bred from, brother to sister, for a total of 12 generations, alluninjected, ofNC and
CN hybrids; these served as controls. In the MNC and MCN groups from F5
onwards there were some mice, offspring of injected animals which early produced
tumours at the site of injection, which were themselves neither injected nor bred
from; these together with the whole ofFln and F12 formed the uninjected MNC
and MCN groups and served as further controls.
Mice ofthe NBT and CBA strains were injected to give the M/NBT and M/CBA
groups, and one uninjected generation (M/NBT F1 and M/CBA F1) was raised from
them. Controls for the M/NBT and M/CBA groups were provided by mice of
these inbred strains which were born during the period of the experiment.
In previous communications the incidences of tumours at the site of injection
(Miller and Pybus, 1954a), of lung tumours (Miller and Pybus, 1954b) and of
mammary tumours (Miller and Pybus, 1954c) in this same material have been
described.
The experiment was begun in October, 1945, but no stomachs were opened until
December, 1946, when a large squamous epithelioma was found in the stomach
of an injected F1 animal. The stomach of every mouse dying after that date was
opened and examined carefully for benign and malignant tumours. All post-
mortems made before that date have been excluded from the present report.FORESTOMACH TUMOURS IN MICE
Throughout the following pages the word "tumour" without qualification
refers to forestomach tumours only. Tumours were also found in the glandular
part of the stomach, and will be described at a later date.
The forestomach tumours were of two main types, papillomata and gross
malignant tumours. The papillomata varied in size from the smallest visible
sessile or pedunculated nodule to quite large sessile or pendunculated arborescent
masses half-filling the forestomach, and in number from solitary tumours to 7
or more in one stomach. Sections were cut of many of those found early in the
experiment and, while the majority proved to be benign, a number showed
early malignancy in the downgrowth ofthe epithelial cells through the muscularis
mucosae. As it became impossible to examine microscopically every papilloma
no attempt has been made to classify them as malignant or benign.
In addition to these papillomata there occurred a few grossly malignant tum-
ours, the largest of which formed large solid masses in the abdomen. These were
sectioned; and while some were pure squamous epitheliomata, others were pure
spindle-celled tumours and still others were found to consist of a mixture of both.
Lateral invasion of the glandular area was seen, so that sometimes the main
tumour mass appeared to be in the pyloric end. Extensive infiltration and meta-
stases were sometimes found throughout the peritoneum and chest; in one case
there was invasion of a lymph node on the oesophagus.
Adequate descriptions and illustrations of benign and malignant forestomach
tumours in mice, with which the present instances are in complete agreement,
have beengiven byStewart (1941), Collins, Gardner andStrong(1943), Stewart and
Lorenz (1949), Bagshaw and Strong (1950), and Peacock, Beck and Chalmers
(1953). No sarcomata of the forestomach were seen in their feeding experiments
by Stewart and Lorenz (1949), but were obtained after remote injection by
Bagshaw and Strong (1950), who doubted the sarcomatous nature of the tumours,
and by direct injection by Firminger and Stewart (1951).
Since forestomach tumours, in common with tumours of the lungs and of
other internal organs, were found only at autopsy, and since papillomata appeared
to be of very slow growth, the age at which they developed cannot be stated,
and "tumour age" became synonymous with the age at death. Thus "tumour
age" will seem to be earlier in shorter-lived strains like the NBT than in those
oflonger life like the CBA, and earlier in males than in females ifthe former died
at an earlier age than the latter. "Age at death" probably approximates most
closely to "tumour age "in the injected mice, where more mice were dying in the
earlier age groups, but the spontaneous type is essentially a tumour ofmiddle and
old age.
The following tumour incidences are based on the effective numbers of mice
forming each group, i.e. the number living to the age of discovery of the earliest
tumour in that group.
RESULTS.
A. Pure Straim.
1. Spontaneous tumours.
As in other respects, so the NBT and CBA strains differed in the incidence of
spontaneous forestomach tumours, all of which were papillomata. Table I gives
the tumour incidences and ages. In the NBT strain 28 females in 240 and 7
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TABLE I.-The Incidence ofForestomach Tumours in Control NBT and CBA Mice,
in Mice of the Same Strains Receiving One Subcutaneous Injection of 1.0 mg.
Methylcholanthrene, and in the One Uninjected Generation Inbred from these
Injected Mice.
Earliest
tumour
Strain. Sex. (months).
NBT .
CBA }22
M/NBT . } 105
M/CBA } 18-0
M/NBT F1 F } 110
MM/CBA F1 } 200
M/CBA F1 F 20 M
Eff-
tive.
number
of
mice.
240
214
No.
28
7
Per-
centage.
11-7 7.7 3-3J
Tumour mice.
t
A
-I
Age at death (months).
Range. Average.
1290-23-0 14158
9.0-17-0 14 0
172 4 2-3 1 22-028-0 25-3
109 0 o.S 1-422.0-28. 0 25. 3 109 0
.
22 17 77-3 6710-5-17-5 14-7
6 0 0- 60-7 - -
4 4 100-0 45.5 20-0-27-0 23-0 220
7 1 143 0 15-0 - 15.0
68 20 29-4122 4 11-0-22-5 17- 716-4
66 10 15-2 11-5-19-0 14-2
162 7 4.3 3 7 20-0-30-0 27 0 251
109 3 2 8 200-24-0 21-71 *
Non-tumour mice.
Age at death (months).
Range. Average.
9-0-24-0 14-2133 9-0-22-0 12.313 3
22-0-44-0 26-7 261 22-0-34-0 25.3261
11-0-16-0 13-8125 10-5-12-5 11.4
20-0-26-0 22-3
11-0-21-0 16.5is
11-0-18-5 13-9
20-0-34-0 26- 1 247
20-0-25-0 22-8
males in 214 had these tumours; as the males died 2 months earlier than the
females, the sex-difference in tumour incidence, which was significant,l* could be
due to the shorter life of the males. Non-tumorous mice of both sexes died on
an average 2 months earlier than tumorous mice; the percentage tumour inci-
dences of 11-7 (females) and 3.3 (males) may not therefore be a complete
expression of the strain susceptibility.
In the CBA strain only 4 tumorous mice, all females, were seen. Non-
tumorous males and females lived as long as, or longer than, the tumorous. The
CBA strain therefore had a much lower degree of susceptibility than the NBT,
the difference being significant,2 and tumours were found much later than in the
NBT.
2. Induced tumours.
Tumours were found in the M/NBT group in 17 of the 22 females living to
10 months and over, autopsied after December, 1946. Only 6 males fulfilled these
requirements and none had tumours, possibly because none lived longer than one
year. The non-tumorous females lived to about the same age as the tumorous.
One tumour was a large spindle-celled sarcoma, the remainder were papillomata.
The difference in tumour incidence between the sexes was significant,3 as was the
increase in incidence in the injected females compared with the controls,4 in spite
of the earlier deaths of the former. The control males had a significantly higher
incidence5 than the injected males (3.3 per cent compared with nil), but some of
the former lived to a maximum of22 months, whereas the maximum for the latter
was 12-5 months (Table I).
The numbers ofM/CBA mice surviving to tumour age (18 months) and autop-
sied after December 1946 were very small. All 4 females but only one of the 7
* For 1 and following numbers see Appendix.
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males had tumours, a significant difference6 and possibly a real one, since all the
non-tumour males lived beyond tumour age. Two females had large epithelio-
mata ofthe forestomach, the remaining tumours being papillomata. The tumour
incidence was significantly higher in the injected females (100 per cent) than in
the controls,7 but in the injected males (14.3 per cent) the increase was not
significant owing to the small numbers involved.
3. Uninjected M/NBT F1 and M/CBA F1.
These mice were the generation raised from inbreeding the injected pure strain
animals. As in the pure strain controls, all the tumours were papillomata.
In M/NBT F1 twice as many females as males were tumorous, a significant
difference,8 but one which could again be explained by the earlier deaths of the
males. Although the non-tumorous males lived about as long as the tumour
males, they died 2.6 months earlier than the non-tumorous females (Table I).
Compared with the control NBT group, the F1 tumour incidences of29.4 per cent
(females) and 15.2 per cent (males) were significantly higher.9 This supports
the earlier statement that the control tumour incidences might have been higher
if the mice had lived longer, for the M/NBT F1 non-tumour females lived on the
average nearly as long as the F, tumour females and 2 months longer than the
controlNBTnon-tumour females, thusgivinggreateropportunityforatrue expres-
sion ofthe strain susceptibility. The F1 non-tumour males also lived longer than
the control non-tumour males, by 1.6 months.
Comparing the tumour incidences in the F1 and the M/NBT groups, the inci-
dence in the F1 females was significantly less'0 although the F1 females lived much
longer; the incidence in the F1 males should be compared not with that in the
injected males (which were very few in number and died young) but with that in
theinjected females; these livedto the same age, yet the F1 male tumourincidence
was very much less.
In the M/CBA F1 group, although there were fewer tumours in the males
(again due to their earlier deaths), the difference in tumour incidence between
the sexes was not significant and the incidences were also in agreement with those
of the CBA controls, males and females. Compared with the injected M/CBA
group, the F1 females had a significantly lower tumour incidence,' but the inci-
dence in the males, although less in F1, was not significantly so on account of the
small number ofM/CBA males.
Since the apparent sex differences in tumour incidence were most probably
due to different survival times, the average incidences for both sexes combined
in each group were compared and the following results obtained. Tumour
incidences in the NBT and uninjected M/NBT F1 groups were higher than in the
CBA and uninjected M/CBA F1 groups, but in the injected mice of both strains
they were the same, the carcinogen having obliterated the strain difference.
Tumours were much more frequent in the two injected groups than in the controls
and malignant tumours were found after injection but not in the controls. The
uninjected descendants of each M/NBT and M/CBA group had lower incidences
than their injected parents, but, whereas M/CBA F1 had the same incidence as
the CBA controls, the tumour incidence in M/NBT F1 was higher than that in
the NBT controls because the F, mice lived longer.
10
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4. Multiple papillomata.
The effect of the methylcholanthrene was seen not only in the increased
incidence oftumorous mice but also in the increased number (and size) oftumours
per mouse, as shown in Table II.
NBT strain.-In the control NBT group the majority of tumorous mice each
had only one small nodule in the forestomach, but 4 (11-4 per cent) females had
2 nodules each. Ofthe 17 tumorous M/NBT mice 7 (41.2 per cent) had 2 or more
TABLE II.-The IncidenceofMultiple Papillomata andofGross Malignant Tumours
of the Forestomach in Control and Injected Tumorous Mice Belonging to the
Inbred NBT and CBA Parent Strains and the First Two Generations of
Reciprocal Hybrids.
Genera-
Strain. tion.
NBT . . -
Number
of
tumour
Sex. mice.
F . 28
M . 7
Mice with multiple
papillomata.
A
No. Percentage.
4 143 14 0 0.o}1.
Maximum
counted
number
ofpapil-
lomata
per
stomach.
2
1
Number
of mice
with
gross
malignant
tumours.
0
0
F . 17
M . 0
F1 . F . 20
M . 10
F . 4
M . 0
- . F . 4
M . 1
5 400 0\40 0 4 40-0f
0 - 0.00 .0 ..
0 0.0
0 0-0 0.0 I 0 00
3* . 1
0 . 0
6* . 0
3 . 0
1 . 0
0 . 0
1 . 2
1 . 0
F1 . F . 7 . Not stated
M . 3 . in records
0
0
. Fl . F . 10
M . 3
F2 . F . 13
M . 14
F1 . F . 10
M . 5
F . F . 9
M . 8
F1 . F . 10
M . 13
3 30-o 231 0 0-0
0 0.0j
1 20 0
0 0j
022.2}11.8
5 50.0 56-5 5 61-5j
F2 . F . 29 . 14 48-3 378
M . 16 . 3 188 8
F1 . F . 21 . 16 76.2 714
M . 14 . 9 64- 3
F2 . F . 35 . 21 600 553 M . 12 . 5 41-7
* = Large number, uncounted, recorded as "multiple."
3 . 1
1 . 0
3* . 0
1 . 1
2 . 0
2 . 0
2 . 0
1 . 0
2* . 2
6 . 1
4* . 3
4 . 2
4* . 4
6* . 0
7* . 3
3 . 1
M/NBT
M/NBT
CBA
M/CBA
M/CBA
NC
NC
CN
CN
MNC
MNC
MCN
MCN
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nodules each, one mouse having 3 and anotherso manythattheywerenot counted.
This increase is statistically significant.2 There were as many tumour mice with
multiple papillomata in the M/NBT F1 group as in the injected group, the maxi-
mum number counted in one mouse being 6, while another had so many that they
were recorded simply as "multiple ". Although the F1 mice were the longest-
lived, this does not seem to be sufficient explanation of this result.
CBA strain-In the various CBA and M/CBA groups all the recorded occur-
rences were of solitary nodules. This is a further proof of the greater suscepti-
bility of the NBT strain towards the formation of forestomach papillomata.
B. Hybrid Strains-First Two Generations.
1. Spontaneous tumours in F1 and F2.
In these two generations the numbers of mice available for analysis were con-
siderably reduced by the necessity of omitting all dying before December 1946.
Data for the incidence offorestomach tumours are given in Table III.
In each of the four groups, NC Fl, NC F2, CN F1 and CN F2, the tumour inci-
dences in the two sexes were in agreement. Where they appeared to differ widely,
as in NC F1 and CN F1, the numbers were small, the males died 4 or 5 months
earlier than the females, but the differences were not statistically significant.
Where the males lived as long as the females, as in NC F2 and CNF2, the incidence
in the males was slightly higher than in the females, but not significantly so.
In all four groups the non-tumour mice lived as long as the tumour mice and the
average age at death was about 2 years. Comparing the various groups the tum-
TABLE III.-The Incidence of Forestomach Tumours in Control and Injected Mice
of the First Two Generations ofReciprocal Hybrids.
Earliest
tumour
Sex. (months).
F } 16-5
M
Effec-
tive
number
of
mice.
57
38
Tumour mice.
r A
--
Per-
No. centage.
10 17.5}13.7
3 7-9
Age at death (months).
Range. Average.
16-5-35-0 278264
21-5-23.0 22-0
NC F2 * F 16-5 103 13 12-613.2 19-0-29-0 24-5V23 7
M f 101 14 13-91 16-5-28-0 23-0
CN F1 * F 17 5 54 10 18-5143 19-5-34-0 2732
M f7 5
51 5 9-.f 17-5-28-0 23-2 59
CN F2 * F 18-0 117 9 77 8.2 18-0-28-5 239237
M 90 8 8-9 20-5-25-5 23-5
MNC F1 * F 9.0 17 10 58-8 57514-0-26-0 188 5 M f 23 13 56-5f 5 9-0-29-5 18-3.
MNC F2 . F}
M
MCN F1 . F
M
MCN F2 . F
M
6-0
8-0
8-0
94 29 30
97 16 16 5fU
27 21 77 8
28 14 50 0O
74 35 47-3
60 12 20-035
6-0-24-5 16-0
8-5-22-5 14-f15 5
9-0-24-0 18-2
8-0-28-0 18-9185
8-0-28-0 156 5i
9-0-18-5 13-5
Non-tumour mice.
Age at death (months).
A_
Range. Average.
18-0-35-0 270 25 2
16-5-31-5 22-8 *
16-5-31-5 24-1 23-6
16-5-31-5 23-0f236
17-5-34-0 27-225
17-5-31-5 23-91
18-0-32-5 27-6V243
18-0-31-0 22-71 2
9-0-31-0 15 16-4
10.5-32.0 1657916
6-0-26-5 11-6
6-0-23-0 11.7
8-0-28-5 20-0 16
8-5-24-0 15.4J16 8
8-0-28-5 15-4 139
8-0-27-0 12-6519
Strain
and
generation.
NC F1
147E. W. MILLER AND F. C. PYBUS
our incidences were all found to be in agreement, NC F1 with NC F2, CN F1 with
CN F2, NC F1 with CN F1, and NC F2 with CN F2, the differences between percen-
tages being less than twice the standard errors in all cases.
The tumour incidences in NC F1 and CN Fl were compared with those ofNBT
and also ofM/NBT F1, the latter on the assumption that it more truly represented
the pure strain incidence owing to longer life. In none ofthe cases were the differ-
ences significant. The incidence in the F1 hybrids was, therefore, that of the
parent NBT strain-there was no sex-difference and no difference according to
the direction of the cross.
As the mice ofthe early hybrid generations were long-lived, their tumours were
found much later than those in the NBT mice and in this respect they resembled
the other parent strain, the CBA. Although the tumours were of slow growth
and could therefore have been present for a long time before death, yet mice dying
in the younger age-groups were tumour-free, and it is believed that tumour
development actually took place much later in the hybrids, being a function of
the normal length of life ofthe mice.
With the exception of one gross epithelioma in an NC F1 female and one in
an NC F2 male, the spontaneous tumours in the four groups were all papillomata.
2. Induced tumours in F1 and F2.
Data for tumour incidence in these generations of injected mice are given in
Table III. The incidences were all much higher in the injected groups than in
the controls. There was no sex-difference in tumour incidence in MNC F1,
but in the other three groups the incidences were significantly less in the males
than in the females.3 In MCN F1 and MCN F2 the non-tumour males died on
the average several months earlier than the females, and in MNC F2 the non-
tumour mice of both sexes died at a very early average age.
Comparing MNC F1 with MNC F2 and MCN F1 with MCN F2, the drop in
tumour incidence in the F2 mice was significant in both cases,l4 and could be ex-
plained by the fact that the average age at death of injected F2 mice was from
3 to nearly 5 months earlier than that of injected F1 mice. There was no corres-
ponding significant decline in the tumour incidence in the control F2 mice, in
which the decrease in the average age at death from F1 to F2 was much less.
Tumour incidences in MNC F1 and MCN F1 were in agreement, but the inci-
dence of 23.6 per cent in MNC F2 was significantly lower than that of 35.1 per
cent inMCNF2. Separate analysis showed that the difference layin the females,',
the incidences in the males being in agreement. The non-tumorous MNC F2
females died 4 months earlier than the non-tumorous MCN F2 females and also 4
months earlier than the tumorous MNC F2 females; the tumour susceptibility
ofthe MNC F2 females was therefore probably not fully expressed.
Comparisons were made between the tumour incidences in the injected F1
and F2 hybrids and in the corresponding groups of controls. In every case the
incidence in the injected mice was significantly higher.16 As shown in Table III,
tumours were found in injected mice from 7-5 to 8.5 months earlier than in the
controls.
While the majority of tumours were papillomata, some of which showed signs
of early malignancy, a number of large malignant growths were found in the
injected mice (Table II). Thus there were 3 epitheliomata in MNC F1 and 5
(one consisting of mixed epithelioma and sarcoma elements) in MNC F2; the 4
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gross tumours in MCNF1 included one pure sarcoma, 1 mixed epithelioma-sarcoma
and 2 pure epitheliomata, and there were 4 epitheliomata in MCN F2.
3. Multiple papillomata.
As shown in Table II, the number of tumour mice bearing multiple papillo-
mata was much lower in the control hybrids than in the injected hybrids. Widely
though the percentages with multiple nodules vary between NC F1 and F2 and
CN F1 and F2, none of the differences is significant and the percentages do not
differ significantly from the proportion of NBT tumour mice bearing multiple
papillomata. One NC F1 mouse had 3 nodules, one in NC F2 had so many that
they were not counted, and another in F2 had 3 nodules.
The contrast in the injected hybrids was striking. Except in MNC F2, the
percentage oftumour mice bearing 2 or more nodules was over 50 per cent in each
group. The maximum number counted in one stomach was 7, but many were
recorded as "multiple". In spite of quite wide fluctuations, the proportions
with multiple nodules agreed amongst themselves in the different groups of injec-
ted hybrids (the difference being always less than twice the standard error) and
all were significantly greater than in the corresponding control groups17 (the differ-
ence being always greater than twice the standard error).
As stated in a previous communication (Miller and Pybus, 1954b), there was a
possibility that some mice ofthe control F1 groups (NC F1 and CN F1) might have
become contaminated with methylcholanthrene either by contact with, or by
licking injected mice ofthe same litters kept in the same boxes; the lung tumour
incidences in these two groups were as high as in the injected F1 mice. From the
present data there is no positive evidence either from actual tumour incidence
or from the percentages with multiple papillomata that such contamination, if
it occurred, was sufficient to cause an increased incidence offorestomach tumours.
The onlypossible evidence was, first, the case oftheNC F1 mouse bearing 3 papillo-
mata (but one NC F2 mouse had 3, and another "multiple", nodules and there
was no possibility that any control F2 animal had come in contact with the carcino-
gen) and, second, the finding of a large malignant epithelioma in an NC F1 mouse
(but again an F2 animal was found to have a large malignant epithelioma, pre-
sumably spontaneous).
c. Hybrid Strains-All Generations.
1. Spontaneous tumours, NC and CN groups.
The data for spontaneous tumours in each generation of the NC and CN
groups are given in Table IV, the figures for F1 and F2 being repeated from Table
III for convenience ofcomparison. Comparing the same sexes, the totalincidences
for the 12 generations of 10.6 per cent for NC females and 8.5 per cent for CN
females were in statistical agreement, as were the incidences of 5.5 per cent in
both male groups.
In the NC group, although the incidences in the two sexes differed greatly in
most generations, none of the differences was significant, but the totals of 10.6
per cent in females and 5*5 per cent in males in the 12 generations did differ
significantly18 (difference- 5.1, twice standard error - 3.3). In the CN group,
the sex-differences in F9 and Fu1 only were significant'9 (in F9, difference 10.0,
twice standard error = 9*5; in Fl1, difference = 7.1, twice standard error = 6.9),
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Strain number
and of
generation. Sex. mice. No.
NC
F1 . F .
M
F2 . F
M
F3 . F
M.
F4 . F
M.
F5 . F
M.
F, . F
M.
F7 . F
M.
F, . F
M.
F, . F
M.
Flo . F.
M.
F11 . F
M .
Fs, . F
M
Fg F
F12 . F
M
57
38
103
101
54
43
60
46
40
46
45
27
22
46
48
56
36
36
31
35
23
9
28
26
547
509
10
3
13
14
9
1
4
5
3
0
3
0
1
2
7
2
4
1
1
0
1
0
2
0
58
28
Per-
centage.
175 13.7 7-9
126}13.2
10:9} 8.5
139 3.5
4-2
6 7} 4*2 .65 8-7 9 6.9
11 3}1.5
0.7
16 8.71
2-8
302 1.5 3.20
404 3.1
0:1
701 3.7
5.5
(
1
2
1
1
1
1
1
1
1
1
2
1
1
1
1
1
TABLE IV.-The Incidence of Spontaneous Tumours of the Forestomach in Each
Generation of Control NC and CNHybrids.
Tumour mice.
Non-tumour mice.
Age at death (months). Age at death (months).
Range. Average. Range. Average.
16-5-35*0 27*8 V264 .18-0-35-0 27-0 25-2
115-23-0 22-0 4 16-5-31-5 2258
L9-0-29-0 24-5 23 . 16-5-31*5 24-1231 6 L6-5-28-0 23.0f2" . 16-5-31.5 23-0f
L3-0-29-5 23-6 23 2 11*0-30*0 20*9 18-4 L9.5 - 1951 8*0-31-0 15-91
L925-27_ 0 24-6}19*6 9-0-29 0 22 5 20 3 ~2-5-19*0 15-6f 8-0-25.0 17-2
A40-26-0 20- 20 0 9 0-2740 217 419} - - - 9-0-24*0 17.4
L6-5-21-5 216}21-6 8:0-25]0 19}17.5
2o0 - 220 3 1 6:0-28:0 20·117} 4 90-185-2-0 13'5 8 .5- 31 . 16-2.
L4-5-26-5 21-2 20 . 9-0-27-0 19-5 \15.5 36-0-21-5 188 . 8-0-23-0 12-4
L4 0-21-0 17-4 15-5 9-0-22-0 17-315} 8_0 - 820 ' 380200 13.45
8-0 - 80} 8-0 8:0-]290 17 7}14-6
1.0 = ilO}1.0 80-2450 17 L 14 9 ~~~~~8-0-15-0 10-9f
L2-5-14-0 13-313.3 9-0-23-0 14 0 - - - f 9. 80-20 13-3
80-35-0 22-721-8 * 8-0-35-0 21.-118.9 8-0-28-0 19-9J . 8-0-31-5 16-8
CN
F1 . F:
F, . F
M.
F3 . F
M.
F4 . F
M
F, F
Fs . F
M. F6 F.
M.
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54 .
51
117
90
40
33
35
36
28
23
25
13
10
5
9
8
7
4
4
6
3
0
2
0
12 1}14.3
17.5}14
11'4}14.1 16 7}14
0.0 5-9
5.3
19-5-34.0
17-5-28-0
18-0-28-5
20-5-25-5
10-0-28-5
12-5-23-0
22-0-29-5
11-0-25-0
8-0-26-5
21-0-26-5
27-3 25-9 23-2
23 5} 23 7 2.~23.7 '
17 4 22.5}20.6'
25-222.4 20-2
19.0}19.0
23.8}23 8
17- 5-34-0
17.5-31 5
18-0-32-5
18-0-31-0
10-0-32-0
9 0-28 0
9-0-29-0
8-0-28-0
8-0-33-0
8-0-23-0
11-0-27-0
8-0-14-0
27:2 25-3 23-
227}624.3 22-2
18 6
20'4 18 3
16.1
22'-4 19.4
16 2}19
1o 8}16
A
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Strain
and
generation. Sex.
Effective
nuraber
of
mice.
TABLE IV-ont.
Tumour mice.
t I-
Per-
No. centage.
Age at death (months).
Range. Average.
Non-tumour mice.
Age at death (months).
Range. Average.
F7 . F . 24 . 1 4-2 1.9
M . 29 . 0 0.0
20- 0 20.}200
F8 . F . 38 . 4 10.5 8 20-5-27.5 24-61 M . 39 . 2 5.1lf 5 9.5-11.5 10-519
F9 . F . 40 . 4 100 6.7
M . 20 . 0 0.0
25.0-30-0 26-6}2606 26.6~26.6 '~~~~
Flo . F. 53 . 2 38} 3\ 4 16.0-22-0 19.0}17.2 M . 36 . 1 2 8 135
- 1351
F1 . F .o56 . 4 7-1 4 _ M 28 . 0 0.0f
F12 . F . 116 .
M . 131 .
3
3
F1-Fl2 . F . 620 . 53
M . 529 . 29
2 6} 2-4 18.5-24.5 21.7 186
'
2.3 2 13.0-27.0 15 5.
8*5 5} 71 5.5
8-0-34-0 23-322 1
9.5-28.0 19 9
8-0-30.0 17-61 8-0-24.0 12-7-14.9
10.0-28-0 20.61 8-0-23-0 12 363
9.0-32-0 2031 8.0-14.0 10 f16.8
8.0-28-0 17-91 8.0-18-.0 1274-15.6
8.0-24-0 15613 8.0-15.0 9.5135
8.0-29.0 163 148 8-0-19-0 1314.8
8.0-34*0 193Y173 8S0-31.5 1590 7.3
andthedifference between thetotalsforthe 12generations of8-5per centinfemales
and 5.5 per cent in males was barely significant (difference = 3-0, twice standard
error = 2.99). In both groups the males died several months earlier than the
females, and this is believed to account for the difference in tumour incidences
in the two sexes.
In the later generations of both groups there was a tendency towards earlier
death in both sexes and this is reflected in the trend towards lower tumour inci-
dences in later generations, this trend being noticeable in spite ofthe wide fluctua-
tions from generation to generation. While there might be a genetical basis for
the diminishing incidences, it was not possible to discern this in the case of a
tumour essentially ofold age and with such a low incidence in younger mice that
often there was only a solitary occurrence, or even none, in a small generation
in which many mice died young.
Spontaneous gross malignant tumours were rare, none being seen in the CN
group, and (in addition to those mentioned earlier) only 1 in an NC F3 female and
2 in NC F8 females, all squamous epitheliomata, giving a total in NC of 4 gross
tumours in females and 1 in a male.
Multiple papillomata. All the other spontaneous tumours in these groups
were papillomata, the great majority being solitary. In NC (F3 to F12) only 2
out of 5 F3 tumour males and 1 out of 7 F8 tumour females each had 2 papillo-
mata; including F1 and F2 (Table II) this gave a total of 6 cases of multiple
nodules in 58 tumour females (10-4 per cent) and 2 in 28 tumour males (7.1 per
cent). This difference was not significant. In the control CN mice (F3 to F12)
1 F4 female had 2 papillomata, the remainder being solitary. With F1 and F2
(Table II) this gave a total of 5 cases of multiple nodules in 53 tumour females (9.4percent) and 1 in 29males(3.4percent), again aninsignificantdifference. The
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incidences of multiple nodules in the two control groups were in agreement for
both males and females.
2. Induced tumours, MNC and MCN groups.
Table V presents the data for the tumour incidence in each generation of the
injected hybrids, the figures for F1 and F2 being repeated from Table III for
comparison. There was wide variation in tumour incidence between the sexes.
In MNC F1, F3, F6 and FE this difference was not significant, but in the remaining
generations andin the totals for all 10generations in this group the differences were
significant.20 In the MCN group the sex-difference in tumour incidence was
significant in F1, F2 and F3 and in the total for the 10 injected generations.21
In both injected groups the non-tumour mice died young, their average age being
several months less than the average tumour age, but the difference in age at
death between males and females was much less constant than in the control
NC and CN hybrids.
In bothgroups there was a decreasein tumourincidenceinthelatergenerations
compared especially with F1 and F2, and this was paralleled by a decrease in
the average survival age of the mice. The very low incidences in the last 5
generations ofMCN were due to the earlydeaths, veryfew miceliving to the age of
18 months.
The total tumour incidences in the two injected groups were in agreement,
females with females (27-7 per cent in MNC, 27-2 per cent in MCN) and males with
males (12.5 per cent in MNC, 14.1 per cent in MCN). There was also very little
difference between the average ages at death of tumour mice in the two groups,
and also ofnon-tumour mice.
Tumour incidences were significantly higher in the MNC and MCN hybrids
than in the control NC and CN groups,22 by as much as two to three times, and
tumours were found much earlier in the injected groups-by about 8 months.
Multiple papillomata.-Table VI shows the incidence of multiple papillomata
in the injected MNC and MCN generations. Nearly 50 per cent of the injected
tumorous mice had 2 or more nodules each, and whereas in the controls (where
less than 10 per cent of tumorous mice bore 2 or more nodules) the maximum
number counted in one individual was 3, in the injected mice the maximum num-
ber counted was 9, and there were many cases recorded simply as "multiple ",
the papillomata being so numerous.
The proportions oftumour-bearing injected mice in the two groups which had
multiple papillomata were in agreement (48.8 per cent of 168 MNC tumour females
and 46.0 per cent of 124 MCN tumour females; 37.1 per cent of 89 MNC tumour
males and 44.6 per cent of 65 MCN tumour males) and there was no significant
sex-difference.
There were 26 cases of gross epitheliomata and sarcomata in the MNC mice
and 16 cases in the MCN mice.
3. The uninjected MNC and MCN groups.
Table VII gives the incidence of spontaneous tumours in these descendants
ofinjected mice. In the uninjected MNC group the differences between the sexes
were not significant except in F12 (a large generation) and in the totals for F5 to
F12.23 Tumour incidence fluctuated from generation to generation, and the totals
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TABLE V.-The Incidence of Forestomach Tumours in Each Generation of
Methylcholanthrene-injected MNC and MCN Hybrids.
Tumour mice.
Per-
centage.
56. 57} 5
30.9 23.6 16.5
1627 3 21.7
46: 7 369 27.3~
27.3 ).36.9
363 20*3 46.Of
18-4
18:4 15-0 11.8
16'7 9.4
3}1 258}12 4
281 5.0
15:9}10-1
27*7 195 12.5
577 8}63.6
47.3351 20-0).31
51.1 31. 9 13 o}319
30:5}29 1
310}25-0
O. 0. 0
0. 0
72 4-9 2 -9
0.1 2.4
407 4.4 4.70
Effective r-
Strain number
and of
generation. Sex. mice. No.
MNC
F1 . F
M
F, 2 F
M
F3 . F
M
F4 . F
M
Fs . F
M
Fe, . F
M
F7 . F
M
Fs . F
M
F, . F
M
F10 . F
M
F1-Flo . F
M
MCN
F1 . F
M
F . F
M
F3 . F
M
F4 . F
M
F, . F
M
F, . F
M
F7 . F
M
F, . F
M
F, F
M
F1,1 F
M
F,-Fl·F
M
17 . 10
23 . 13
94 . 29
97 . 16
33 . 9
36 . 6
107 . 50
110 . 30
60 . 23
88 . 7
49 . 9
51 . 6
84 . 14
96 . 3
31 . 8
50 . 2
62 . 5
79 . 2
69 . 11
80 . 4
606 . 168
710 89
27
28
74
60
45
46
59
58
58
66
12
13
25
25
53
70
39
44
64
50
21
14
35
12
23
6
18
16
18
13
0
0
0
0
4
2
2
0
3
2
Non-tumour mice.
Age at death (months). Age at death (months).
Range. Average. Range. Average.
14-0-26-0 18-8 . 9 0-31 0 15.9V16.4
9 0-29 5 1803 105-320 167
6-0-24*5 160 *1O . 6*0-26-5 11 6 116 865-22*5 14-5 l . 6.0-230 11-7
5-0-23-0 13-812 0 * 5-0-17-0 9.5 8.6 6-5-115 939 . 5.0-13.0 7 8
5'5-26'5 13'4 12.0 4-0-29'0 9 4 8-6 4-0-19-5 9 7 . 4.0-24-0 7 9
5'0-245 10-4 10. 4.0-23.5 79 76 5.0-20.5 9.2 . 4-0-18-0 7 4
6.0-23.5 11-4 4-0-23.5 8-8 11410.9 7' 7-0-16.5 10-1 . 4.0-17.0 7 4
7.0-27.0 16'4 15 . 4.0-28-0 90 87 8.5-16-5 11-5f5 . 4.0-20.0 895·
5-0-25'0 12·8 129 . 4-0-24-0 100 82
6-0-20.0 13-0 . 5.0-17.0 7 4
14-5-22.0 18-4 16 . 40-23-0 87 91
6-5-13-5 10.0 . 4·0-22·0 9 4
11.5-27.0 17'6176 . 4.0-22-0 79 89 16.0-19.0 17-6 . 4.0-25.0 9.6
5-0-27.0 14.3 13 6 4-0-310 93 91 4-0-29-5 12-3 . 4.0-32.0 8 9 1
9-0-24*0 18.2 10 . 8.0-28.5 20-°016 8 8*0-28-0 18 9f . 8'5-24.0 15.4
8 0-28*0 15.6 1o 8 0-28 5 15.4 13 9 9-0-18.5 13*5 . 80-27-0 12 6
5-5-27*0 17-6168 . 6-0-2670 12.4L19 9.0-19.5 135f 5.0-28.0 11.7
5-5-21-5 10-5 10 4.0-26.0 10-4 9 4 6-0-20-0 10-1S1 4-0-24-0 8 5r
7-5-24-5 13-0 12 . 4-0-23-0 9.7 9 7 4-0-19-5 10-5 2 . 4-0-26-0 9-7r
4-0-20-0 12-3 8 7 - - - . 4 0- 8l0 5*5r
5-- 17-0 9.3 8 9 4-0-16-0 8.4) -
7o5-115 9.5 o 4*0-170 7 8 0
12-0-18-5 15f315.3 4-0-170 7.48j 3
125-195 142.129 4.0-17.0 86 86 9-5-1-5 11.-0 4.340-150 86
. 456 . 124 27.2 20 6 5 5-28-0 15-1 144
. 460 . 65 141 4.0-28.0 13 0 4*0-28.5 104 99 4.0-28.0 9.4
I
I
I
I
t
I
I154 E. W. MILLER AND F. C. PYBUS
TABLE VI.-Incidences of Multiple Papillomata and of Gross Malignant Tumours
of the Forestomach in Each Generation of Methylcholanthrene-injected MNC
and MCN Hybrids.
Number
Strain of
and tumour .
generation. Sex. mice.
Fl . . F . 10
M . 13
F2. . F . 29
M . 16
F3 F . 9 .
M . 6
F4. . F 50
M . 30
Fs . . F . 23
M . 7
F6. F . 9
M . 6
F7. . F . 14
M . 3
F8 . . F . 8
M . 2
Fg . . F . 5
M . 2
F,o . . F . 11
M . 4
Fl-Flo . F . 168
M . 89
F . 21
M . 14
F 35
M . 12
F 23
M . 6
F . 18
M . 16
F . 18
M . 13
F 0
M . 0
F . 0
M . 0
F . 4
M . 2
Mice with multiple
papillomata.
r A- -
No.
5
8
14
3
8
3
30
16
9
2
6
0
4
0
2
1
1
0
3
0
82
33
16
9
21
5
6
2
8
9
6
4
0
0
0
0
0
0
Percentage.
5°.°56 5 61.5f5.
48-33 18.8 37.8
88.9) 50 0 73.3 60.0
60} 57.5
39.13 28 6 367
667}400
0 0.0
286}23 5
25.0~ 25°0 30.0
20.0~ 20 0 14 3
27.3}200
37 1 44.7 37-1~~~~~
76*2
64 3 71.4
60.0
41 7 55.3
26.1}
33 3 27-6
44-4
56.3 50.0
33-3
30*8 32-3
0g0}
0. 00.0
0.0l
0.0 0.0
0.0~
0.° 0.0
Maximum
counted Number
number of of mice
papillomata with gross
per malignant
stomach. tumours.
2* . 2
6 . 1
4* . 3
4 . 2
5 . 0
2* . 0
9* . 7
3* . 4
5 . I
2 . 0
4 . 0
1 . 0
3 . 2
1 . 0
2 . 0
5 . 0
2 . 1
1 . 1
3 . 2
1 0
9* . 18
6* . 8
4*
6*
7*
3
4*
4
5
5*
4
6
0
0
0
0
1
1
4
0
3
1
6
1
0
1
0
0
0
0
0
0
0
0
MCN
F1
.
F2
F4
F7
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TABLE VI-cont.
Maximum
counted Number
Number Mice with multiple number of of mice
Strain of papillomata. papillomata with gross
and tumour r A per malignant
generation. Sex. mice. No. Percentage. stomach. tumours.
MNC
F, . F . 2 . 0 0 0 . 1 . 0
M . 0 . 0.0 0 0.
F1o. . F . 3 . 0 0.0 0 1 . 0
M . 2 . 0 0. 1 . 0
Fx-Flo . F . 124 . 57 46.0 45 7* . 13
M . 65 . 29 44 6 45-5 6* 3
* = Large number, uncounted, recorded as "multiple."
of 9'3 per cent for females and 4.4 per cent for males were in agreement with
the control NC values of 10.6 per cent and 5.5 per cent respectively (Table IV).
The ages at death of the tumorous and non-tumorous uninjected MNC mice were
also comparable with the control values.
The uninjected MCN mice died young and the tumour incidences (1.9 per
cent in females and 1-5 per cent in males) were low. The sex-differences were
nowhere significant. The tumour incidences were significantly less than those
in the uninjected MNC mice, and also significantly less than those in the CN
controls.24
There was no evidence that the increased incidence and earlier appearance
of forestomach tumours in the injected mice were characteristics continued in
their uninjected descendants. Especially in F12 of the uninjected MNC hybrids,
a very large generation and one that was preceded by 10 generations of injected
mice and one ofuninjected, the tumour incidences of 10-8 per cent in the females
and 5.0 per cent in the males were in agreement with the total incidences of 10.6
per cent and 5.5 per cent respectively in the NC controls.
Multiplepapillomata.-Table VIII shows the incidence ofmultiple papillomata
in the 8 generations ofuninjected MNC mice. The maximum individual number
was 3 in anFn1 mouse. The total incidences of7.7 per cent in 78 tumorous females
and 2*1 per cent in 48 tumour males (not a significant difference) did not differ
significantly from the corresponding values in the control NC hybrids. There
were 6 cases of malignant epitheliomata in the uninjected MNC group, 4 ofwhich
were quite small tumours and none was so florid as those found in the injected
mice.
Of the few tumorous mice in the uninjected MCN group none had multiple
papillomata, but 2 malignant epitheliomata, both rather small, were found in F5.
D. Malignant Tumours.
Bagshaw and Strong (1950) found that malignant epidermoid carcinomata
of the forestomach appeared earlier than benign papillomata. The ages at death
of all mice in the present experiment bearing malignant forestomach tumoursEffective -
Strain number
and of
generation. Sex. mice. No.
MNC (uninj.)
F5 . F
M
F6 . F
M
F7 . F
M
F8 . F
M
F9 . F
M
F10 F
M
F11 F
M
F12 * F . F
M
F5-F12 FF
M
27
35
. 100
. 112
77
77
42
46
34
44
80
77
. 147
. 209
. 334 · 440
· 841
. 1040
0
1
· 14
7
4
5
3
1
2
0
9
4
. 10
6
. 36
. 22
· 78 · 46
Per-
Per-
centage.
001-6
2 9}-9 14-0\ 9.9
653
5.} 5-9
4.5
7-2} 4-5
0 O}2.6
752
6.-6
113} 8.3
2-9 6·8} 4·5
5-0 10.8} 7·5
4 4
Age at death (months).
Range. Average.
16-5 -
19-0-28-0
15-5-23-5
19-0-27-0
15-5-27-0
24-0-27-0
250 -0
20-0-25-5
15-0-26-5
18-5-26-0
6-0-28-5
14-5-23-5
12-0-28-5
14-5-23-5
6-0-28-5
14-5-27-0
- }
253 22-7
26'0}21
26-0}25-8s
22.8}22 8
20 9}21-1 21- 6
192} 19-'7
202 5
22'3}21.2 19-5
22-1214 202321.4
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TABLE VII.-The Incidence of Forestomach Tumours in the Uninjected Offspring
ofInjected Hybrids.
Tumour mice.
Non-tumour mice.
Age at death (months).
Range Average Range. Average.
6-0-27-0
7-0-29-0
6-0-29-0
6-0-30-0
6-0-29-0
6-0-26-0
9-0-28.-0
6-0-26-0
6-0-28-0
8-0-26-0
7-0-28-0
6-0-27-0
6-0-26-0
6-0-25-0
6-0-28-0
6-0-28-0
6-0-29-0
6-0-30-0
58 5}16-9
15.5
20-919. 4 18-1
21 0}18-5
15-
21 5}17 7
14 3
20 2}18-3
19749}18 6
174
17 8}17.1
16 6
19 6}18 7 18- 1
17'9}17.1 16 5
MCN (uninj.)
F6 . F
M
F6 . F
M
F7 . F
M
F8 . F
M
F9 . F
M
F10 . F
M
Fs F
F11 . F
M
F12 . F
M
F6-F12 F
M
38
49
3
2
17
24
31
38
40
36
46
38
90
85
114
125
379
397
1
3
0
0
0
0
1
0
1
2
1
0
2
0
1
1
7
6
26 4-6
0.0} 0.0 0.0
30 2 135 0.0.0
2-5 3.9 5} 6
0.0 1-9
g:9} 0-8
1-1
0-
0:8} 0.8
1.9} 1 7
23-5 - 23-5 199 10-0-25-0 18 7 199
-i -
16.0 }- 16-0 16.0}160
18-0 - 18-0 16-2
14-5-16-0 15.3j
18.5 }- 18-5 18.5}185
14-0-15-5 14.8}148
17-0 17-05 14-0 - 14-0155
14.5-23-5 17-5172 10-0-25-0 16 8172
11-0-25-0
11-0-25-0
16-0-20-0
14-0-21-0
10-0-18-0
12-0-17-0
11-0-19-0
10-0-17-0
11-0-21-0
10-0-22-0
10-0-19-0
10-0-20-0
10-0-24-0
10-0-21-0
10-0-20-0
10-0-17-0
10-0-25-0
10-0-25-0
19- 3 18 7
18-3f
17 5}17-8
14. }14 4
14.82
13- 4 14.2
14-8f
13} 9
2}13 2
12.:}3
13 6}13 3
13 13
14'8}14.4 13-FORESTOMACH TUMOURS IN MICE 157
TABLE VIII.-Incidences ofMultiple Papillomata and ofGross Malignant Tumours
of the Forestomach in Each Generation of Uninjected Descendants of Injected
MNC Mice.
Maximum
counted Number
Number Mice with multiple number of of mice
Strain of papillomata. papillomata with gross
and tumour A per malignant
generation. Sex. mice. No. Percentage. stomach. tumours
MNC
(uninjected)
F . . F . 0 . 0 0.0 0 . 0
M . . 0 00 1 . 0
F6 F 14 0 0. 0}2-0 2 3
F,. . F . 14 . 0 0 0 1 . O
M . 7 . 0 0.0 1 0.
F7. F . 4 0 00 111 I 0
M. 5 1 20.0 2 . 0
F?. F . 1 0 3 . 2 . 0
M . . 1 0 0.0 0
F,. . F 2 0 1 0
M 0 0 0.0 0. 1 0
F1l. F . 9 . 2 222 54 ' 2 . 0
M . 4 . 0 00 . 1 . 0
F11.l F 10 I 10.0 6-3 . 3 1
M 6 0 0.0 1 0
F12. F . 36 2 5'6V34 2 0
M . 22 0 0 1 2
F-F . F . 78 . 6 77 5 3 4
M . 46 . 1 2-2 2 . 2
are shown in Table IX, for comparison with the average ages of discovery of
all forestomach tumours, benign and malignant, given in Tables I, IV, V and
VII. With a few exceptions, the ages of discovery of spontaneous and induced
malignant gross tumours were slightly greater than the corresponding average
ages for all tumours. It must again be pointed out that " tumour age " in the
present experiment was the age at which the tumour was discovered, that a
tumour might have been present in the animal for some time before death, and
that a gross malignant tumour could be the cause of death. Stewart and Lorenz
(1949)makea sharpdistinction betweenbenign papillomata andgross carcinomata,
stating that the former do not necessarily lead to the latter; and in the present
material there were instances where both types were present in the same stomach.
DISCUSSION.
Very few references have been-found in the literature to the presence of spon-
taneous benign papillomata of the forestomach in mice. Stewart and Andervont
(1938) quote Bonne (1927) who found 2 mice with stomach papillomata in a total
of 146 controls, and Stewart and Lorenz (1949) found solitary papillomata in
control mice receiving mineral oil. Peacock, Beck and Chalmers (1953) saw na
spontaneous papillomata in 86 control mice, but found 3 in 99 mice treated with158 E. W. MILLER AND F. C. PYBUS
TABLE JX.-The Ages at Death of Mice Bearing Malignant Forestomach Tumours.
Individual ages
(months).
K -A_
Females.
13-5
20-0,27- 0
29-0
25-0
17-5, 26-5
19.0, 23.5, 26.5
20-0
23-5
Average
ages.
.-A -"
Males. Females.
~- ~ . 13-5 ~- . 23-5
16-5
29-0
25-0
22-0
23-0, 23-5
10.0
Males. Females.
. 13-5
. 23-5
16-5 24.524.5
. 23-0 - ·20-0 22-3
23-3 J
23-5 10-0 . 23-5
Total "spontaneous" average age (hybrids).
20-5,21-0
20-0, 19-0, 24- 5
19-5,5-0
20-0, 21-5, 20-0, 10.0,
19-0, 14-0, 12-0
19-5, 14-0
140, 16-0
18-0
15-0
12-0,21-0
21-0,23-0,11-5,14-5
17-5, 16-0, 25-5
.26-5,21-5,26-5,23-0
22-5,18-5
9.0
9-0
14-5, 10-5
13-5, 40, 13-0
19.5
13-5
16-5
17-0
7-5, 7-5
20-8
21-2
12-5
16-6
16-8
15-0
18-0
15.0
16-5
17-5
19-7
23-1
9.0
9.0
12-5
12-5
13-5
16-5
17-0
7-5
Total "induced " average age (hybrids)
17.1
19-8
12-2
12-1
. 18- 1 12-2
control solvents. They are tumours of infrequent occurrence which could
readily escape observation unless the stomachs of all mice were submitted to rou-
tine examination at autopsy. Very occasional examples have been seen in recent
years in this laboratory in the A and GFF strains. In the present case it happened
that 2 inbred strains, NBT and CBA, were crossed, in which the incidences of
this tumour, although small, differed significantly. In the reciprocal hybrids
the incidence did not vary with the direction of the cross and was similar to that
of the NBT strain-the parent strain with the higher incidence. The tumour
occurs in middle and old age, and the observed incidence was therefore very closely
connected with the average age ofthe mice at death, relative to the normal length
of life of the strain. Thus the incidence in males was usually less than that in
Strain
and
generation.
M/NBT
M/CBA
NC
F2
1
Fl F,j F4
Uninj. MNC
F6· Fl,
F11 F12
Uninj. MCN
F5
Group
averages.
11 A
Males.
16-5
23-3
10'0
. 23-4 18-3
MNC
F1
F,
F3
F4
F5
F7
Fg
F,
Flo
MCN
F1
F8
F3
F4FORESTOMACH TUMOURS IN MICE
females, because the males tended to die sooner; where they lived as long as the
females the tumour-incidence was the same in both sexes. It is therefore believed
that this tumour-incidence shows no real sex-difference, but because ofthe appar-
ent sex-difference it has been thought more accurate to give the incidences in the
two sexes separately and, in comparing two groups of mice, to compare females
with females and males with males.
Although spontaneous malignant tumours of the forestomach were not seen
in the two parent strains they have been known to occur occasionally in mice
(Slye, Holmes and Wells, 1917; Wells, Slye and Holmes, 1938; Collins, Gardner
and Strong, 1943; Jackson Memorial Laboratory, 1941). A few were found in
the hybrids in the present experiment in mice which at no time had been, or could
have been, exposed to methylcholanthrene (unless, as Beck (1952) suggested
for benzpyrene, there had been some slight contamination of boxes with the
carcinogen from previous occupants which had been injected); malignant tumours
found in the F1 mice must of course be suspect.
In spite ofthe rarity ofthe spontaneous gastric neoplasm, benign and malignant
forestomach tumours have been produced experimentally in mice since 1927.
Historical surveys of experimentally induced gastric tumours, up to 1940, have
been given by Stewart (1940) and by Klein and Palmer (1941). Since then, Lorenz
and Stewart (1940, 1948), Stewart (1941) and Stewart and Lorenz (1942, 1949)
have published several reports on the induction of forestomach tumours by oral
administration of carcinogens as well as by direct injection (the method by which
they produced the first experimentally-induced glandular gastric carcinoma).
Collins, Gardner and Strong (1943) induced benign and malignant forestomach
tumours by intra-vaginal instillation and by oral administration of carcinogens,
while Strong (1945) and Bagshaw and Strong (1950) obtained similar tumours
in mice exposed to the carcinogen by remote injection, as in the present work.
Although Gardner (1941) and Collins, Gardner and Strong (1943) believed that the
tumours developed in those mice receiving the carcinogen by the vaginal route
because the mice licked themselves and each other, thus swallowing some of the
carcinogen which had oozed out, they obtained fewer tumours in this way than
by direct oral administration; and Bagshaw and Strong (1950) did not think
that the small amount obtained bylicking could account for the tumours produced
in their experiment.
It has already been shown (Miller and Pybus, 1954b) that the control F1 mice
in the present experiment apparently obtained enough methylcholanthrene by
licking their injected litter-mates to increase the lung tumour incidence to that
in injected mice. Evidently the quantity of carcinogen thus received was not
sufficient to raise the incidence of forestomach papillomata in the control F1
mice above normal. The stomach tumour incidence in the injected mice was
very much greater than that in the controls and the tumours appeared many
months earlier, while, in addition to the increased proportion of tumorous mice,
the number ofpapillomata per stomach was also greatly increased, and epidermoid
carcinomata as well as sarcomata and mixed tumours were present in much
greater numbers. There can be no doubt that the increase was due to the methyl-
cholanthrene, but the effect in the present material did notpersist in theuninjected
descendants of the injected mice; these uninjected mice had a tumour incidence
similar to that ofthe controls, even when they were descended from 10 generations
ofinjected animals.
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The incidence of forestomach tumours in mice treated with carcinogens has
been found to depend on the strain of mice. Strain differences were found by
Gardner (1941), Collins, Gardner and Strong (1943) and by Lorenz and Stewart
(1940, 1948), while Strong, Collins and Durand (1943) and Bagshaw and Strong
(1950) found a difference between two sublines, one ofwhich produced forestomach
tumours and the other glandular gastric tumours. Susceptibility has been found
to depend also on the carcinogen used as well as on its mode of administration.
In the present work two inbred strains of mice with different incidences of spon-
taneous forestomach tumours were injected, but their susceptibilities to methyl-
cholanthrene were the same; admittedly the numbers of injected mice surviving
to tumour age were small, the carcinogen used was one of the more potent (Klein
and Palmer, 1941; Lorenz and Stewart, 1948), and the dose was large.
SUMMARY.
1. Two inbred strains ofmice, CBA andNBT, which differed in theincidence of
spontaneous papillomata of the forestomach, were crossed reciprocally. A
number of mice from the parent strains and from ten inbred generations of the
hybrids each received one subcutaneous injection of 1.0 mg. methylcholanthrene
at the age of two months.
2. The incidence of spontaneous forestomach papillomata in the hybrids did
not vary with the direction of the cross and was the same as that of the more
susceptible parent strain, the NBT, but the tumours appeared much later, as in
the CBA strain. There was no real sex-difference in incidence, but only an
apparent one caused by the earlier deaths of the males.
3. A few epidermoid carcinomata of the forestomach, presumed to be spon-
taneous, were seen in hybrids not exposed to the carcinogen, but none occurred in
the parent strains.
4. In the injected groups the incidence oftumorous mice was greatly increased,
the number ofpapillomata per stomach was also increased, and the tumours were
produced many months earlier than in the controls. The incidence of malignant
tumours of the forestomach (epidermoid carcinomata, sarcomata, and mixed
carcino-sarcomata) was increased.
5. Injected members of the two inbred strains and the F1 hybrids all had the
same incidence of induced forestomach papillomata. In the later hybrid genera-
tions the induced tumour incidence fell as fewer mice survived to old age.
6. There was no evidence that the increased tumour incidence in the injected
mice was maintained in their uninjected descendants, even after ten injected
generations. The incidence in the uninjected descendants was similar to that
in the controls.
This investigation was carried out with the aid of a research grant from the
North of England Council of the British Empire Cancer Campaign. The authors
would like to take this opportunity to make belated acknowledgment ofa generous
gift of methylcholanthrene received from Dr. G. M. Smith, of Yale University,
during the early stages ofthis work at a time when supplies of the chemical were
difficult to obtain in this country.
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APPENDIX
Statistics ofsignificance for 8ignificant differences only
Groups compared.
NBT Y v.c·
NBT Y v. CBA.
NBT& v. CBA .
NBT +- J v. CBA +·
M/NBT Y v. c '
M/NBT 9 v. NBT
M/NBT 3 v. NBT '3
M/CBA v.
MCBA Y v. CBA
M/NBT F1 v. d
M/NBT F1 S v. NBT
M/NBT F1 S v. NBT S
M/NBT F1 v. M/NBT.
M/CBA F1 v. M/CBA 9
M/NBT v. NBT
MNCF2 v.'.
MCN F19 v. .
MCN F2 v. 3 . . .
MNC F1 9 v. MNC F2
(3 significant by inspection)
MCN F1 $ v. MCN F2 9
MCN F1 S v. MCN F2
MNC F2 9 + - v. MCN F2 9 +
MNC F2 9 v. MCN F2 9
MNC F1 v. NC F1
MNC F2 v. NC F2
MCN F1 v. CN F1
MCN F2 v. CN F2.
MNC F1 v. NC F1
MNC F2 v. NC F2
MCN F1 v. CN F1.
MCN F2 v. CN F2
NC 9 v. c3 (total)
CN Fg v..
CN Fll v. .
CN 9 v. ( (total)
MNC F49 v..3
MNC F59 v. . .
MNC F7 9v. . .
MNC Fs8 v. J .
MNCFlo v. .
MNC 9 v. c3 (total)
MCNF3 9 v. CT
MCN 9 v. c (total)
MNC v. NC ·
MNC c v. NC . .
MCN 9v. CN9
MCN S3 v. CN ··
uninj. MNC F2 9 v.C
uninj. MNC 9 v. c (total)
uninj. MCN 9 v. uninj. MNC 9
uninj. MCN d3 v. uninj. MNC d
uninj. MCN ? v. CN 9 .
uninj. MCN C3 v. CN c
T.
Difference.
8.5
9.3
3.3
6.3
77.3
65 6
3.3
85.7 97.7
14.26
17.7
11.9
47.9
95.7
29 8
14*4
27.8
27.3
27.9
30.5
30 0
11.5
16*4
43.8
10*4
39.3
26 9
33.1
30.4
51.4 43.5
5.1
10.0
7.1
3.0
19.4
28-3
13 6
21-8
10.9
15.2
38.1
13.1
17.1
7.0
18.7
8.6
5*8
4.9
7.4
2.9
6.6 4.0
Fe
Twice
standard error.
4.8
4.7
2*4
5.1
17.9
18.3
2*4
26*5
2-0
14-16
11.8
9.2
21.9
3.2
13.1
12.2
24.8
15.5
19.6
19.8
21.5
10.3
15.0
17-2
7.8
14.7
9-1
31.2
17 6
25-7
21.3
3.3
9.5
6 9
2.99
12-9
13.7
8 9
16 7
10-1
4-4
17*9
5.3
4.5
3*2
4.7
3.8
3.98
2.4
2.4
1.8
2.6
2-3
Index
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
11
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